- Home
- SERA vs PCF Comparison
SERA vs PCF Comparison
Compare SERA & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SERA | PCF |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.3M | 116.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SERA | PCF |
|---|---|---|
| Price | $2.61 | $6.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 57.1K | ★ 74.8K |
| Earning Date | 03-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.90% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $95,000.00 | N/A |
| Revenue This Year | $25.84 | N/A |
| Revenue Next Year | $715.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.06 | N/A |
| 52 Week Low | $1.37 | $5.71 |
| 52 Week High | $6.58 | $6.96 |
Technical Indicators
Market Signals| Indicator | SERA | PCF |
|---|---|---|
| Relative Strength Index (RSI) | 30.62 | 35.10 |
| Support Level | $3.30 | $6.08 |
| Resistance Level | $2.93 | $6.17 |
| Average True Range (ATR) | 0.19 | 0.04 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 3.54 | 0.00 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.